Terazosin 23155-0736
Product NDC
23155-0736- Manufacturer
- Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 30, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA075614
Need to source Terazosin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Terazosin Hydrochloride | 2 mg/1 |
Drug Class
Adrenergic alpha-Antagonists [MoA]alpha-Adrenergic Blocker [EPC]
Packaging Options(2)
100 CAPSULE in 1 BOTTLE (23155-736-01)
1000 CAPSULE in 1 BOTTLE (23155-736-10)